Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

Exclusion Criteria

• •Subjects with existing scars or significant striae on the abdominal pannus
• •Females who are currently pregnant or pregnant during the 12 months prior to inclusion in the study, or lactating
• •Participation in another clinical trial within 30 days prior to the start of the study
• •Any other condition or prior therapy, which, in the opinion of the PI, would make the subject unsuitable for this study